On the public citation graph
American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer
0 signed · 1059 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archinte.147.12.2177openalex-snapshot
Treatment of deep vein thrombosis and pulmonary emboli in patients with primary and metastatic brain tumors. Anticoagulants or inferior vena cava filter?
inferredcites →https://doi.org/10.1001/archinte.158.6.585openalex-snapshot
Trends in the Incidence of Deep Vein Thrombosis and Pulmonary Embolism
inferredcites →https://doi.org/10.1001/archinte.160.2.181openalex-snapshot
A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous Thromboembolism
inferredcites →https://doi.org/10.1001/archinte.160.6.809openalex-snapshot
Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism
inferredcites →https://doi.org/10.1001/archinte.162.11.1245openalex-snapshot
Relative Impact of Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism
inferredcites →https://doi.org/10.1001/archinte.162.15.1729openalex-snapshot
Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer
inferredcites →https://doi.org/10.1001/archinte.164.15.1653openalex-snapshot
Outcomes and Cost of Deep Venous Thrombosis Among Patients With Cancer
inferredcites →https://doi.org/10.1001/archinte.164.9.963openalex-snapshot
Risk Factors for Venous Thromboembolism in Hospitalized Patients With Acute Medical Illness
inferredcites →https://doi.org/10.1001/archinte.166.4.458openalex-snapshot
Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Common Cancers
inferredcites →https://doi.org/10.1001/archsurg.1992.01420030076014openalex-snapshot
Postoperative Pulmonary Embolism After Hospital Discharge
inferredcites →https://doi.org/10.1001/jama.1976.03260440032018openalex-snapshot
Prevention of Venous Thrombosis With Small, Subcutaneous Doses of Heparin
inferredcites →https://doi.org/10.1001/jama.293.6.715openalex-snapshot
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
inferredcites →https://doi.org/10.1001/jama.296.21.2558-copenalex-snapshot
Thalidomide- and Lenalidomide-Associated Thromboembolism Among Patients With Cancer
inferredcites →https://doi.org/10.1002/1097-0142(19840515)53:10<2046::aid-cncr2820531007>3.0.co;2-fopenalex-snapshot
Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate: Final Report of VA cooperative study # 75
inferredcites →https://doi.org/10.1002/1097-0142(19940115)73:2<493::aid-cncr2820730240>3.0.co;2-dopenalex-snapshot
Therapy of venous thromboembolism in patients with brain metastases
inferredcites →https://doi.org/10.1002/1097-0142(19940701)74:1<38::aid-cncr2820740108>3.0.co;2-eopenalex-snapshot
Subcutaneous heparin treatment increases survival in small cell lung cancer
inferredcites →https://doi.org/10.1002/14651858.cd001217openalex-snapshot
Heparins and mechanical methods for thromboprophylaxis in colorectal surgery
inferredcites →https://doi.org/10.1002/ana.410130320openalex-snapshot
Incidence and treatment of peripheral venous thrombosis in patients with glioma
inferredcites →https://doi.org/10.1002/bjs.1800751105openalex-snapshot
Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery
inferredcites →https://doi.org/10.1002/bjs.1800820421openalex-snapshot
Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 Xal units in 2070 patients
inferredcites →https://doi.org/10.1002/bjs.1800820603openalex-snapshot
Thromboprophylaxis in malignant disease
inferredcites →https://doi.org/10.1002/bjs.1800840817openalex-snapshot
Efficacy and safety of enoxaparinversus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment
inferredcites →https://doi.org/10.1002/bjs.4309openalex-snapshot
Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma
inferredcites →https://doi.org/10.1002/cncr.21496openalex-snapshot
Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study
inferredcites →https://doi.org/10.1002/cncr.22892openalex-snapshot
A meta‐analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment
inferredcites →https://doi.org/10.1002/cncr.23524openalex-snapshot
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
inferredcites →https://doi.org/10.1002/jso.20625openalex-snapshot
Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis
inferredcites →https://doi.org/10.1007/s11239-006-9001-zopenalex-snapshot
Prevalence of Factor V 1691 G–A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients
inferredcites →https://doi.org/10.1016/0002-9378(93)90360-uopenalex-snapshot
A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery
inferredcites →https://doi.org/10.1016/0140-6736(92)91054-copenalex-snapshot
Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis
inferredcites →https://doi.org/10.1016/0140-6736(92)91708-gopenalex-snapshot
Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma
inferredcites →https://doi.org/10.1016/0197-2456(94)00031-wopenalex-snapshot
Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists
inferredcites →https://doi.org/10.1016/j.amjmed.2005.06.058openalex-snapshot
Incidence of Venous Thromboembolism in Patients Hospitalized with Cancer
inferredcites →https://doi.org/10.1016/j.amjmed.2006.02.022openalex-snapshot
Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer
inferredcites →https://doi.org/10.1016/j.amjmed.2006.03.030openalex-snapshot
Self-Managed Long-Term Low-Molecular-Weight Heparin Therapy: The Balance of Benefits and Harms
inferredcites →https://doi.org/10.1016/j.critrevonc.2006.05.001openalex-snapshot
Venous thromboembolism and cancer: Guidelines of the Italian Association of Medical Oncology (AIOM)
inferredcites →https://doi.org/10.1016/j.ejca.2004.06.023openalex-snapshot
Risk factors for catheter-related thrombosis in cancer patients
inferredcites →https://doi.org/10.1016/j.eururo.2007.05.028openalex-snapshot
Multi-institutional Study of Symptomatic Deep Venous Thrombosis and Pulmonary Embolism in Prostate Cancer Patients Undergoing Laparoscopic or Robot-Assisted Laparoscopic Radical Prostatectomy
inferredcites →https://doi.org/10.1016/j.jvs.2007.02.017openalex-snapshot
Low-molecular-weight heparin in patients with advanced cancer: A phase 3 clinical trial
inferredcites →https://doi.org/10.1016/s0002-9343(02)01345-1openalex-snapshot
Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)
inferredcites →https://doi.org/10.1016/s0002-9343(97)89484-3openalex-snapshot
Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis
inferredcites →https://doi.org/10.1016/s0002-9610(70)80023-xopenalex-snapshot
Deep vein thrombosis of the leg
inferredcites →https://doi.org/10.1016/s0012-3692(15)32912-3openalex-snapshot
Ultrasonographic Evaluation of Liver/Spleen Movements and Extubation Outcome
inferredcites →https://doi.org/10.1016/s0029-7844(01)01601-5openalex-snapshot
Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial
inferredcites →https://doi.org/10.1016/s0029-7844(02)02444-4openalex-snapshot
Venous thromboembolism prophylaxis: patients at high risk to fail intermittent pneumatic compression
inferredcites →https://doi.org/10.1016/s0140-6736(59)91464-3openalex-snapshot
PREVENTION OF VENOUS THROMBOSIS AND PULMONARY EMBOLISM IN INJURED PATIENTS
inferredcites →https://doi.org/10.1016/s0140-6736(75)90494-8openalex-snapshot
PREVENTION OF FATAL POSTOPERATIVE PULMONARY EMBOLISM BY LOW DOSES OF HEPARIN *1An International Multicentre Trial
inferredcites →https://doi.org/10.1016/s0140-6736(94)90008-6openalex-snapshot
Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer
inferredcites →https://doi.org/10.1016/s0140-6736(96)91009-0openalex-snapshot
Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases
inferredcites →https://doi.org/10.1016/s0140-6736(97)10018-6openalex-snapshot
Venous thromboembolism and cancer
inferredcites →https://doi.org/10.1016/s0305-7372(02)00043-9openalex-snapshot
Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis
inferredcites →https://doi.org/10.1016/s0959-8049(97)00052-xopenalex-snapshot
Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983–1987)
inferredcites →https://doi.org/10.1038/sj.neo.7900263openalex-snapshot
The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate
inferredcites →https://doi.org/10.1046/j.1365-2168.1997.d01-3882.xopenalex-snapshot
Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment
inferredcites →https://doi.org/10.1055/s-0037-1613051openalex-snapshot
Venous Thrombosis in Patients with Solid Tumors: Determination of Frequency and Characteristics
inferredcites →https://doi.org/10.1055/s-0037-1613749openalex-snapshot
Prevention of Venous Thromboembolism in Internal Medicine with Unfractionated or Low-molecular-weight Heparins: A Meta-analysis of Randomised Clinical Trials
inferredcites →https://doi.org/10.1055/s-0037-1614885openalex-snapshot
The Effects of Unfractionated Heparin on Survival in Patients with Malignancy – A Systematic Review
inferredcites →https://doi.org/10.1055/s-0037-1615937openalex-snapshot
Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer Spread
inferredcites →https://doi.org/10.1055/s-0037-1616771openalex-snapshot
The Effects of Vitamin K-antagonists on Survival of Patients with Malignancy: A Systematic Analysis
inferredcites →https://doi.org/10.1055/s-0038-1650276openalex-snapshot
Thrombosis in Cancer Patients Treated with Hematopoietic Growth Factors - A Meta-Analysis
inferredcites →https://doi.org/10.1055/s-0038-1657514openalex-snapshot
Prevention of Post-operative Deep Leg Vein Thrombosis in Patients with Cancer
inferredcites →https://doi.org/10.1056/nejm198805053181805openalex-snapshot
Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin
inferredcites →https://doi.org/10.1056/nejm199705223362107openalex-snapshot
Management of Anticoagulation before and after Elective Surgery
inferredcites →https://doi.org/10.1056/nejm199802123380701openalex-snapshot
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
inferredcites →https://doi.org/10.1056/nejm199807093390204openalex-snapshot
Enoxaparin plus Compression Stockings Compared with Compression Stockings Alone in the Prevention of Venous Thromboembolism after Elective Neurosurgery
inferredcites →https://doi.org/10.1056/nejm199909093411103openalex-snapshot
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
inferredcites →https://doi.org/10.1056/nejm200012213432504openalex-snapshot
Prognosis of Cancers Associated with Venous Thromboembolism
inferredcites →https://doi.org/10.1056/nejmc053530openalex-snapshot
Lenalidomide and Venous Thrombosis in Multiple Myeloma
inferredcites →https://doi.org/10.1056/nejmcp031676openalex-snapshot
Treatment of Deep-Vein Thrombosis
inferredcites →https://doi.org/10.1056/nejmoa012385openalex-snapshot
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
inferredcites →https://doi.org/10.1056/nejmoa025313openalex-snapshot
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
inferredcites →https://doi.org/10.1056/nejmoa032691openalex-snapshot
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
inferredcites →https://doi.org/10.1056/nejmoa041533openalex-snapshot
Electronic Alerts to Prevent Venous Thromboembolism among Hospitalized Patients
inferredcites →https://doi.org/10.1056/nejmoa052367openalex-snapshot
Multidetector Computed Tomography for Acute Pulmonary Embolism
inferredcites →https://doi.org/10.1093/annonc/mdj068openalex-snapshot
Risk factors for venous thromboembolic events in cancer patients
inferredcites →https://doi.org/10.1093/annonc/mdl003openalex-snapshot
Quality of systematic reviews used in guidelines for oncology practice
inferredcites →https://doi.org/10.1093/jnci/90.18.1371openalex-snapshot
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
inferredcites →https://doi.org/10.1093/jnci/djj189openalex-snapshot
Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients
inferredcites →https://doi.org/10.1093/jnci/djj262openalex-snapshot
Effect of Factor V Leiden and Prothrombin G20210→A Mutations on Thromboembolic Risk in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial
inferredcites →https://doi.org/10.1097/00000658-198808000-00016openalex-snapshot
Prevention of Venous Thromboembolism in General Surgical Patients
inferredcites →https://doi.org/10.1097/00001703-199302000-00013openalex-snapshot
Prevention of venous thromboembolism in gynecologic surgery patients
inferredcites →https://doi.org/10.1097/00001721-200306000-00004openalex-snapshot
Prevention of venous thromboembolism in medical patients with enoxaparin
inferredcites →https://doi.org/10.1097/00005792-199909000-00001openalex-snapshot
Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data
inferredcites →https://doi.org/10.1097/00006123-199007000-00010openalex-snapshot
The Risk and Efficacy of Anticoagulant Therapy in the Treatment of Thromboembolic Complications in Patients with Primary Malignant Brain Tumors
inferredcites →https://doi.org/10.1097/00006250-200112000-00002openalex-snapshot
Pneumatic Compression Versus Low Molecular Weight Heparin in Gynecologic Oncology Surgery
inferredcites →https://doi.org/10.1097/00006250-200301000-00029openalex-snapshot
Venous Thromboembolism Prophylaxis: Patients at High Risk to Fail Intermittent Pneumatic Compression
inferredcites →https://doi.org/10.1097/01.sla.0000193832.40178.0aopenalex-snapshot
Incidence and Prevention of Venous Thromboembolism in Patients Undergoing Breast Cancer Surgery and Treated According to Clinical Pathways
inferredcites →https://doi.org/10.1097/01.sla.0000193959.44677.48openalex-snapshot
A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery
inferredcites →https://doi.org/10.1111/j.1365-2141.2004.05327.xopenalex-snapshot
Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients
inferredcites →https://doi.org/10.1111/j.1365-2141.2005.05529.xopenalex-snapshot
Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study
inferredcites →https://doi.org/10.1111/j.1538-7836.2003.tb04581.xopenalex-snapshot
Secondary prevention of venous thromboembolic events (VTE) in patients with active malignancy: a randomized study of enoxaparin sodium alone vs. initial enoxaparin sodium followed by warfarin for a 180-day period
inferredcites →https://doi.org/10.1111/j.1538-7836.2004.00871.xopenalex-snapshot
A randomized clinical trial of combination chemotherapy with and without low‐molecular‐weight heparin in small cell lung cancer
inferredcites →https://doi.org/10.1111/j.1538-7836.2005.01346.xopenalex-snapshot
Factor V Leiden and PT G20210A mutations in cancer patients with and without venous thrombosis
inferredcites →https://doi.org/10.1111/j.1538-7836.2006.01804.xopenalex-snapshot
Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study
inferredcites →https://doi.org/10.1111/j.1538-7836.2006.02153.xopenalex-snapshot
Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open‐label study
inferredcites →https://doi.org/10.1111/j.1538-7836.2007.02374.xopenalex-snapshot
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
inferredcites →https://doi.org/10.1111/j.1600-0609.1995.tb00214.xopenalex-snapshot
Deep venous thrombosis and pulmonary artery embolism in high‐grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance
inferredcites →https://doi.org/10.1136/bmj.309.6964.1286openalex-snapshot
Systematic Reviews: Identifying relevant studies for systematic reviews
inferredcites →https://doi.org/10.1136/bmj.38733.466748.7copenalex-snapshot
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial
inferredcites →https://doi.org/10.1136/bmj.4.5991.257openalex-snapshot
Low-dose heparin prophylaxis against fatal pulmonary embolism.
inferredcites →https://doi.org/10.1159/000081508openalex-snapshot
Low-Molecular-Weight Heparin and Cancer Survival: Review of the Literature and Pooled Analysis of 1,726 Patients Treated for at Least Three Months
inferredcites →https://doi.org/10.1160/th04-03-0189openalex-snapshot
Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients
inferredcites →https://doi.org/10.1160/th04-05-0323openalex-snapshot
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients
inferredcites →https://doi.org/10.1161/01.cir.0000138928.83266.24openalex-snapshot
Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
inferredcites →https://doi.org/10.1161/circulationaha.104.512834openalex-snapshot
Eight-Year Follow-Up of Patients With Permanent Vena Cava Filters in the Prevention of Pulmonary Embolism
inferredcites →https://doi.org/10.1177/106002800303700219openalex-snapshot
Tamoxifen for Prevention of Breast Cancer
inferredcites →https://doi.org/10.1177/1076029606293692openalex-snapshot
Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period
inferredcites →https://doi.org/10.1182/blood-2002-01-0108openalex-snapshot
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
inferredcites →https://doi.org/10.1182/blood-2002-06-1674openalex-snapshot
Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy
inferredcites →https://doi.org/10.1182/blood-2005-07-2817openalex-snapshot
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma
inferredcites →https://doi.org/10.1182/blood-2006-01-0154openalex-snapshot
Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis
inferredcites →https://doi.org/10.1182/blood.v98.5.1614openalex-snapshot
Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy
inferredcites →https://doi.org/10.1200/jco.1989.7.8.993openalex-snapshot
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
inferredcites →https://doi.org/10.1200/jco.1991.9.2.286openalex-snapshot
Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer.
inferredcites →https://doi.org/10.1200/jco.1996.14.10.2731openalex-snapshot
Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.
inferredcites →https://doi.org/10.1200/jco.1997.15.11.3378openalex-snapshot
Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study.
inferredcites →https://doi.org/10.1200/jco.2003.08.046openalex-snapshot
Potential Role of Platelets in Endothelial Damage Observed During Treatment With Cisplatin, Gemcitabine, and the Angiogenesis Inhibitor SU5416
inferredcites →https://doi.org/10.1200/jco.2003.10.066openalex-snapshot
Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer
inferredcites →https://doi.org/10.1200/jco.2004.10.002openalex-snapshot
Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)
inferredcites →https://doi.org/10.1200/jco.2004.11.022openalex-snapshot
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1200/jco.2004.22.14_suppl.750openalex-snapshot
Sentinel node biopsy versus complete axillary clearance in breast cancer: The patients' point of view. Results of a prospective survey
inferredcites →https://doi.org/10.1200/jco.2004.22.14_suppl.8086openalex-snapshot
Primary prevention of venous thromboembolic events (VTE) in cancer patients: An American survey study
inferredcites →https://doi.org/10.1200/jco.2004.99.130openalex-snapshot
Dose Density by Any Other Name
inferredcites →https://doi.org/10.1200/jco.2005.03.0221openalex-snapshot
Phase III Clinical Trial of Thalidomide Plus Dexamethasone Compared With Dexamethasone Alone in Newly Diagnosed Multiple Myeloma: A Clinical Trial Coordinated by the Eastern Cooperative Oncology Group
inferredcites →https://doi.org/10.1200/jco.2005.03.133openalex-snapshot
Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism
inferredcites →https://doi.org/10.1200/jco.2005.03.134openalex-snapshot
The Effect of Low Molecular Weight Heparin on Survival in Patients With Advanced Malignancy
inferredcites →https://doi.org/10.1200/jco.2005.03.5600openalex-snapshot
Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With Cancer
inferredcites →https://doi.org/10.1200/jco.2005.03.8877openalex-snapshot
Thromboembolism in Hospitalized Neutropenic Cancer Patients
inferredcites →https://doi.org/10.1200/jco.2005.04.2150openalex-snapshot
Venous Thromboembolism in Patients With Colorectal Cancer: Incidence and Effect on Survival
inferredcites →https://doi.org/10.1200/jco.2005.05.098openalex-snapshot
Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer
inferredcites →https://doi.org/10.1200/jco.2005.81.908openalex-snapshot
Thromboembolic Events in Gastric Cancer: High Incidence in Patients Receiving Irinotecan- and Bevacizumab-Based Therapy
inferredcites →https://doi.org/10.1212/wnl.27.5.435openalex-snapshot
Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf
inferredcites →https://doi.org/10.1212/wnl.43.6.1111openalex-snapshot
Complications of therapy for venous thromboembolic disease in patients with brain tumors
inferredcites →https://doi.org/10.1245/s10434-006-9183-9openalex-snapshot
A Systematic Review of Deep Venous Thrombosis Prophylaxis in Cancer Patients: Implications for Improving Quality
inferredcites →https://doi.org/10.1378/chest.119.1_suppl.132sopenalex-snapshot
Prevention of Venous Thromboembolism
inferredcites →https://doi.org/10.1378/chest.119.1_suppl.176sopenalex-snapshot
Antithrombotic Therapy for Venous Thromboembolic Disease
inferredcites →https://doi.org/10.1378/chest.126.1.179openalex-snapshot
Inhibition of Bleomycin-Induced Pulmonary Fibrosis by Okam Extract J201
inferredcites →https://doi.org/10.1378/chest.126.3_suppl.172sopenalex-snapshot
The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
inferredcites →https://doi.org/10.1378/chest.126.3_suppl.179sopenalex-snapshot
Applying the Grades of Recommendation for Antithrombotic and Thrombolytic Therapy
inferredcites →https://doi.org/10.1378/chest.126.3_suppl.338sopenalex-snapshot
Prevention of Venous Thromboembolism
inferredcites →https://doi.org/10.1378/chest.126.3_suppl.401sopenalex-snapshot
Antithrombotic Therapy for Venous Thromboembolic Disease
inferredcites →https://doi.org/10.1634/theoncologist.8-4-381openalex-snapshot
Venous Thrombosis in Cancer Patients: Insights from the FRONTLINE Survey
inferredcites →https://doi.org/10.3171/jns.1987.66.3.0357openalex-snapshot
Risk of intracranial hemorrhage in glioma patients receiving anticoagulant therapy for venous thromboembolism
inferredcites →https://doi.org/10.3310/hta9240openalex-snapshot
An evaluation of the costs, effectiveness and quality of renal replacement therapy provision in renal satellite units in England and Wales
inferredcites →https://doi.org/10.3310/hta9380openalex-snapshot
The causes and effects of socio-demographic exclusions from clinical trials
inferredcites →https://doi.org/10.4065/80.12.1549openalex-snapshot
Thalidomide Therapy and Deep Venous Thrombosis in Multiple Myeloma
inferredcites →https://doi.org/10.4065/81.6.758openalex-snapshot
Low-Molecular-Weight Heparin in Patients With Advanced Cancer: A Phase 3 Clinical Trial
inferredcites →https://doi.org/10.7326/0003-4819-130-10-199905180-00003openalex-snapshot
Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis
inferredcites →https://doi.org/10.7326/0003-4819-96-5-561openalex-snapshot
Reduction of Mortality in General Medical In-patients by Low-Dose Heparin Prophylaxis
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4200370openalex-extracted
Development and Validation of a New Risk Assessment Model for Immunomodulatory Drug-Associated Venous Thrombosis Among Chinese Patients with Multiple Myeloma
inferred← citeshttps://doi.org/10.1001/jama.2008.656openalex-snapshot
Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2020.7410openalex-snapshot
Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2023.25283openalex-snapshot
Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2023.35311openalex-snapshot
Venous Thromboembolism Chemoprophylaxis Adherence Rates After Major Cancer Surgery
inferred← citeshttps://doi.org/10.1001/jamaoto.2013.1372openalex-snapshot
Prospective Study of Venous Thromboembolism in Patients With Head and Neck Cancer After Surgery
inferred← citeshttps://doi.org/10.1001/jamaoto.2013.4911openalex-snapshot
Prospective Study of Venous Thromboembolism in Patients With Head and Neck Cancer After Surgery
inferred← citeshttps://doi.org/10.1001/jamasurg.2022.2590openalex-snapshot
Evaluation of Adherence to Venous Thromboembolism Prophylaxis Guidelines Among US Adults After Pancreatic Cancer Surgery
inferred← citeshttps://doi.org/10.1002/14651858.cd008500openalex-snapshot
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
inferred← citeshttps://doi.org/10.1002/14651858.cd008500.pub2openalex-snapshot
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
inferred← citeshttps://doi.org/10.1002/14651858.cd013399openalex-snapshot
Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia
inferred← citeshttps://doi.org/10.1002/14651858.cd013399.pub2openalex-snapshot
Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia
inferred← citeshttps://doi.org/10.1002/9781118003435.ch6openalex-snapshot
Postoperative Surveillance and Perioperative Prophylaxis
inferred← citeshttps://doi.org/10.1002/9781118067178.ch16openalex-snapshot
Optimizing Inpatient Anticoagulation: Strategies for Quality Improvement
inferred← citeshttps://doi.org/10.1002/9781118067178.ch5openalex-snapshot
Prevention of Venous Thromboembolism in Medical Patients
inferred← citeshttps://doi.org/10.1002/9781118067178.ch6openalex-snapshot
Prevention of Venous Thromboembolism in Surgical Patients
inferred← citeshttps://doi.org/10.1002/9781118375372.ch21openalex-snapshot
Intra‐Abdominal and Pelvic Surgery
inferred← citeshttps://doi.org/10.1002/9781118410875.ch22openalex-snapshot
Prevention and Treatment of Venous and Arterial Thrombosis in Patients with Specific Conditions: Diabetes, Hypercoagulable States, Pregnancy, and Renal Insufficiency
inferred← citeshttps://doi.org/10.1002/9781118590638.ch25openalex-snapshot
Agents for the Management of Hematologic Reactions
inferred← citeshttps://doi.org/10.1002/9781118673768.ch3openalex-snapshot
Side effects and complications of cancer and its treatment
inferred← citeshttps://doi.org/10.1002/9781118833391.ch22openalex-snapshot
An Update on Low‐Molecular‐Weight Heparins
inferred← citeshttps://doi.org/10.1002/9781119095606.ch14openalex-snapshot
Inferior Vena Cava Filters in the Management of Venous Thromboembolism
inferred← citeshttps://doi.org/10.1002/9781119971603.ch9openalex-snapshot
Adults Receiving Chemotherapeutic Regimens
inferred← citeshttps://doi.org/10.1002/9781444307580.ch10openalex-snapshot
Complications of Esophageal Resection
inferred← citeshttps://doi.org/10.1002/acg2.73openalex-snapshot
Cancer‐associated thrombosis: Where do we stand?
inferred← citeshttps://doi.org/10.1002/ajh.21277openalex-snapshot
Hemostatic complications of angiogenesis inhibitors in cancer patients
inferred← citeshttps://doi.org/10.1002/ajh.21423openalex-snapshot
Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: The M. D. Anderson Cancer Center experience
inferred← citeshttps://doi.org/10.1002/ajh.22021openalex-snapshot
Practical aspects of the oral new anticoagulants
inferred← citeshttps://doi.org/10.1002/cam4.1927openalex-snapshot
Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real‐world evaluation
inferred← citeshttps://doi.org/10.1002/cncr.23524openalex-snapshot
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
inferred← citeshttps://doi.org/10.1002/cncr.23525openalex-snapshot
Reply to Frequency, Risk Factors, and Trends for Venous Thromboembolism Among Hospitalized Cancer Patients
inferred← citeshttps://doi.org/10.1002/cncr.24596openalex-snapshot
Venous thromboembolism and nonsmall cell lung cancer
inferred← citeshttps://doi.org/10.1002/cncr.24665openalex-snapshot
Thromboprophylaxis with low‐molecular‐weight heparin in medical patients with cancer
inferred← citeshttps://doi.org/10.1002/cncr.25284openalex-snapshot
Predictors of anticoagulation in hospice patients with lung cancer
inferred← citeshttps://doi.org/10.1002/cncr.25714openalex-snapshot
Venous thromboembolism in the patient with cancer
inferred← citeshttps://doi.org/10.1002/cncr.26302openalex-snapshot
Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis
inferred← citeshttps://doi.org/10.1002/cncr.26597openalex-snapshot
Risk assessment models for cancer‐associated venous thromboembolism
inferred← citeshttps://doi.org/10.1002/cncr.27772openalex-snapshot
Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United States
inferred← citeshttps://doi.org/10.1002/cncr.29536openalex-snapshot
Comorbidity and the risk of venous thromboembolism in prostate cancer
inferred← citeshttps://doi.org/10.1002/hcs2.55openalex-snapshot
Predicting venous thromboembolism (VTE) risk in cancer patients using machine learning
inferred← citeshttps://doi.org/10.1002/hed.22920openalex-snapshot
Venous thromboembolism in patients with head and neck cancer after surgery
inferred← citeshttps://doi.org/10.1002/ijc.27979openalex-snapshot
Risk of venous thromboembolic events associated with VEGFR‐TKIs: A systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1002/jcp.26613openalex-snapshot
Anti‐tumoral effects of low molecular weight heparins: A focus on the treatment of esophageal cancer
inferred← citeshttps://doi.org/10.1002/jcp.27177openalex-snapshot
A randomized clinical trial on the antitumoral effects of low molecular weight heparin in the treatment of esophageal cancer
inferred← citeshttps://doi.org/10.1002/jha2.18openalex-snapshot
A retrospective analysis of venous thromboembolism trends in chemotherapy‐induced anemia: Red blood cell transfusion versus erythrocyte stimulating agent administration
inferred← citeshttps://doi.org/10.1002/jhm.596openalex-snapshot
Guidelines‐based use of thromboprophylaxis
inferred← citeshttps://doi.org/10.1002/jso.23759openalex-snapshot
Outcomes in the management of esophageal cancer
inferred← citeshttps://doi.org/10.1002/jso.26728openalex-snapshot
Evaluating compliance of extended venous thromboembolism prophylaxis following abdominopelvic surgery for cancer: A multidisciplinary quality improvement project
inferred← citeshttps://doi.org/10.1002/jso.27059openalex-snapshot
Risk factors for venous thromboembolism (VTE) after adrenalectomy for adrenal cortical neoplasms
inferred← citeshttps://doi.org/10.1002/ohn.875openalex-snapshot
Is Preoperative Chemoprophylaxis Safe for Venous Thromboembolism Prevention in Patients With Head and Neck Cancer?
inferred← citeshttps://doi.org/10.1002/onco.13596openalex-snapshot
Update on Guidelines for the Management of Cancer-Associated Thrombosis
inferred← citeshttps://doi.org/10.1002/pbc.21734openalex-snapshot
Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer
inferred← citeshttps://doi.org/10.1002/phar.1244openalex-snapshot
Role of the Pharmacist in Achieving Performance Measures to Improve the Prevention and Treatment of Venous Thromboembolism
inferred← citeshttps://doi.org/10.1007/174_2015_1053openalex-snapshot
Cardiovascular Toxicity and Monitoring Methods in Oncologic Patients
inferred← citeshttps://doi.org/10.1007/5584_2016_117openalex-snapshot
Venous Thromboembolism in Brain Tumor Patients
inferred← citeshttps://doi.org/10.1007/978-0-387-79962-9_14openalex-snapshot
Treatment of Venous Thrombosis
inferred← citeshttps://doi.org/10.1007/978-0-387-79962-9_15openalex-snapshot
Effects of Anticoagulants on Cancer: Heparins
inferred← citeshttps://doi.org/10.1007/978-0-387-79962-9_6openalex-snapshot
Overview of Cancer and Thrombosis
inferred← citeshttps://doi.org/10.1007/978-1-4419-1225-1_18openalex-snapshot
Thrombosis and Bleeding in Cancer Patients
inferred← citeshttps://doi.org/10.1007/978-1-4471-5391-7_2openalex-snapshot
General Perioperative Complications
inferred← citeshttps://doi.org/10.1007/978-1-4614-5194-5_12openalex-snapshot
Perioperative Management of Patients with Bone Sarcomas
inferred← citeshttps://doi.org/10.1007/978-1-4614-9560-4_11openalex-snapshot
The Excessively Clotting Cancer Patient
inferred← citeshttps://doi.org/10.1007/978-3-030-20315-3_1openalex-snapshot
Thrombosis and Hemostasis in Cancer. Scope of the Problem and Overview
inferred← citeshttps://doi.org/10.1007/978-3-030-20315-3_6openalex-snapshot
Thrombotic Risk from Chemotherapy and Other Cancer Therapies
inferred← citeshttps://doi.org/10.1007/978-3-030-23417-1_11openalex-snapshot
Anticoagulation in Patients with Brain Metastases
inferred← citeshttps://doi.org/10.1007/978-3-030-23417-1_9openalex-snapshot
Epilepsy in CNS Metastases
inferred← citeshttps://doi.org/10.1007/978-3-030-57273-0_12openalex-snapshot
Cardiac Assessment in Noncardiac Surgery
inferred← citeshttps://doi.org/10.1007/978-3-319-27114-9_4openalex-snapshot
Thromboembolic Disease in the Bariatric Patient: Prevention, Diagnosis, and Management
inferred← citeshttps://doi.org/10.1007/978-3-319-28800-0_14openalex-snapshot
Managing Lymphoma During Pregnancy
inferred← citeshttps://doi.org/10.1007/978-3-319-53686-6_2openalex-snapshot
Venous Thromboembolism Associated with Foot and Ankle Surgery
inferred← citeshttps://doi.org/10.1007/978-3-319-62624-6_13openalex-snapshot
Early Recovery After Surgery Pathways for Pancreatectomy
inferred← citeshttps://doi.org/10.1007/978-3-319-74766-8_66openalex-snapshot
Anesthesia for Nephrectomy with Vena Cava Thrombectomy
inferred← citeshttps://doi.org/10.1007/978-3-319-90990-5_19openalex-snapshot
Thrombosis and Bleeding in Cancer Patients
inferred← citeshttps://doi.org/10.1007/978-3-540-73277-8_6openalex-snapshot
Hematology and Hemostasis
inferred← citeshttps://doi.org/10.1007/978-3-642-05127-2_36openalex-snapshot
Störungen der Blutgerinnung
inferred← citeshttps://doi.org/10.1007/978-3-642-15742-4_34openalex-snapshot
Venous Thromboembolism in Patients with Hematologic Malignancies
inferred← citeshttps://doi.org/10.1007/978-3-642-21496-7_13openalex-snapshot
Thrombosen unter besonderen Bedingungen
inferred← citeshttps://doi.org/10.1007/978-3-662-49480-6_1openalex-snapshot
Venöse Thromboembolien, Thrombophilie und Thromboseprophylaxe in Gynäkologie und Geburtshilfe
inferred← citeshttps://doi.org/10.1007/978-3-662-49480-6_10openalex-snapshot
Venöse Thromboembolien, Thrombophilie und Thromboseprophylaxe in Gynäkologie und Geburtshilfe
inferred← citeshttps://doi.org/10.1007/978-3-662-53955-2_32openalex-snapshot
Notfälle in der Onkologie
inferred← citeshttps://doi.org/10.1007/978-94-007-0618-7_37openalex-snapshot
The Use of Low Molecular Weight Heparin in the Treatment and Prevention of Thromboembolic Disease in Glioma Patients
inferred← citeshttps://doi.org/10.1007/978-981-15-7699-7_14openalex-snapshot
DVT: Prophylaxis and Management
inferred← citeshttps://doi.org/10.1007/978-981-16-9929-0_13openalex-snapshot
Deep Venous Thrombosis and Pulmonary Embolism
inferred← citeshttps://doi.org/10.1007/s00059-015-4378-0openalex-snapshot
Diagnose und Management der akuten pulmonalen Embolie
inferred← citeshttps://doi.org/10.1007/s00066-013-0386-2openalex-snapshot
Risiko von venösen Thromboembolien bei Tumorpatienten, die mit Cisplatin behandelt werden
inferred← citeshttps://doi.org/10.1007/s00104-018-0776-1openalex-snapshot
Evidenzbasierte perioperative Medizin
inferred← citeshttps://doi.org/10.1007/s00120-009-2104-3openalex-snapshot
Supportivtherapie bei Urogenitaltumoren
inferred← citeshttps://doi.org/10.1007/s00129-013-3317-5openalex-snapshot
Venöse Thromboembolien, Thrombophilie und Thromboseprophylaxe in Gynäkologie und Geburtshilfe
inferred← citeshttps://doi.org/10.1007/s00129-014-3478-xopenalex-snapshot
Venöse Thromboembolien, Thrombophilie und Thromboseprophylaxe in Gynäkologie und Geburtshilfe
inferred← citeshttps://doi.org/10.1007/s00268-015-3361-5openalex-snapshot
Post‐Hospital Discharge Venous Thromboembolism in Colorectal Surgery
inferred← citeshttps://doi.org/10.1007/s00270-013-0791-zopenalex-snapshot
Anticoagulant Therapy in Oncologic Patients Undergoing Venous Stenting for Superior Vena Cava Syndrome and Other Interventional Procedures
inferred← citeshttps://doi.org/10.1007/s00270-014-0902-5openalex-snapshot
Anticoagulation is Not Mandatory After Stenting for Malignant Superior Vena Cava Syndrome
inferred← citeshttps://doi.org/10.1007/s00277-008-0561-1openalex-snapshot
Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone
inferred← citeshttps://doi.org/10.1007/s00277-009-0807-6openalex-snapshot
Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide
inferred← citeshttps://doi.org/10.1007/s00277-018-3509-0openalex-snapshot
Frequency of venous thrombotic events in patients with myelodysplastic syndrome and 5q deletion syndrome during lenalidomide therapy
inferred← citeshttps://doi.org/10.1007/s00280-013-2169-yopenalex-snapshot
Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study
inferred← citeshttps://doi.org/10.1007/s00392-018-1202-xopenalex-snapshot
Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome
inferred← citeshttps://doi.org/10.1007/s00404-009-1120-2openalex-snapshot
Minimizing tumor burden by extensive cytoreductive surgery decreases postoperative venous thromboembolism in ovarian clear cell carcinoma
inferred← citeshttps://doi.org/10.1007/s00423-011-0782-yopenalex-snapshot
Standard perioperative management in gastrointestinal surgery
inferred← citeshttps://doi.org/10.1007/s00520-008-0430-4openalex-snapshot
Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study
inferred← citeshttps://doi.org/10.1007/s00520-008-0491-4openalex-snapshot
Long-term use of daily subcutaneous low molecular weight heparin in cancer patients with venous thromboembolism: why hesitate any longer?
inferred← citeshttps://doi.org/10.1007/s00520-011-1330-6openalex-snapshot
Thromboprophylaxis in patients receiving inpatient palliative care: a survey of present practice in Austria
inferred← citeshttps://doi.org/10.1007/s00520-012-1391-1openalex-snapshot
Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients—a pilot study
inferred← citeshttps://doi.org/10.1007/s00520-012-1413-zopenalex-snapshot
Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial
inferred← citeshttps://doi.org/10.1007/s00520-012-1590-9openalex-snapshot
Thrombosis, cancer and renal insufficiency: low molecular weight heparin at the crossroads
inferred← citeshttps://doi.org/10.1007/s00520-013-1742-6openalex-snapshot
Thromboembolic disease in cancer patients
inferred← citeshttps://doi.org/10.1007/s00520-019-05150-zopenalex-snapshot
Development of a clinical prediction tool for cancer-associated venous thromboembolism (CAT): the MD Anderson Cancer Center CAT model
inferred← citeshttps://doi.org/10.1007/s00520-023-07855-8openalex-snapshot
Clinical factors of PICC-RVT in cancer patients: a meta-analysis
inferred← citeshttps://doi.org/10.1007/s00595-014-0890-8openalex-snapshot
Safety of postoperative thromboprophylaxis after major hepatobiliary–pancreatic surgery in Japanese patients
inferred← citeshttps://doi.org/10.1007/s00701-016-2982-2openalex-snapshot
Decision-making in a patient with cardiac arrest due to venous thromboembolism within 24 h after glioblastoma resection
inferred← citeshttps://doi.org/10.1007/s00761-008-1552-5openalex-snapshot
Thromboembolische Komplikationen – Prophylaxe und Therapie im Fokus
inferred← citeshttps://doi.org/10.1007/s00761-010-1793-yopenalex-snapshot
Supportive Therapie bei multiplem Myelom
inferred← citeshttps://doi.org/10.1007/s10120-011-0057-xopenalex-snapshot
Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgery
inferred← citeshttps://doi.org/10.1007/s10143-020-01310-6openalex-snapshot
Pulmonary embolism in neurocritical care-introduction of a novel grading system for risk stratification: the Frankfurt AMBOS score
inferred← citeshttps://doi.org/10.1007/s10147-010-0148-4openalex-snapshot
Pulmonary embolism due to internal jugular vein thrombosis in a patient with non-small cell lung cancer receiving bevacizumab
inferred← citeshttps://doi.org/10.1007/s10388-012-0350-8openalex-snapshot
Utilization of partition analysis to evaluate the incidence on deep vein thrombosis following esophagectomy
inferred← citeshttps://doi.org/10.1007/s10549-012-2334-8openalex-snapshot
Heparins modulate the IFN-γ-induced production of chemokines in human breast cancer cells
inferred← citeshttps://doi.org/10.1007/s10555-012-9357-9openalex-snapshot
Quality of life and supportive care for patients with metastatic renal cell carcinoma
inferred← citeshttps://doi.org/10.1007/s10637-008-9200-xopenalex-snapshot
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors
inferred← citeshttps://doi.org/10.1007/s11239-009-0324-4openalex-snapshot
Highlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23–25, 2008, Sao Paulo, Brazil
inferred← citeshttps://doi.org/10.1007/s11239-009-0405-4openalex-snapshot
Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts
inferred← citeshttps://doi.org/10.1007/s11239-010-0441-0openalex-snapshot
Venous thromboembolism and cancer: a systematic review
inferred← citeshttps://doi.org/10.1007/s11239-010-0445-9openalex-snapshot
Venous thromboembolism risk stratification in medically-ill hospitalized cancer patients. A comprehensive cancer center experience
inferred← citeshttps://doi.org/10.1007/s11239-010-0492-2openalex-snapshot
The AVAIL ME study: a multinational survey of VTE risk and prophylaxis
inferred← citeshttps://doi.org/10.1007/s11239-010-0500-6openalex-snapshot
The eighth American college of chest physicians guidelines on venous thromboembolism prevention: implications for hospital prophylaxis strategies
inferred← citeshttps://doi.org/10.1007/s11239-011-0549-xopenalex-snapshot
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol
inferred← citeshttps://doi.org/10.1007/s11239-011-0555-zopenalex-snapshot
Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure
inferred← citeshttps://doi.org/10.1007/s11239-011-0562-0openalex-snapshot
Anticoagulation in the management of venous thromboembolism in the cancer patient
inferred← citeshttps://doi.org/10.1007/s11239-011-0594-5openalex-snapshot
Standard or extended-duration prophylaxis in medical patients? A review of the evidence
inferred← citeshttps://doi.org/10.1007/s11239-012-0741-7openalex-snapshot
Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: a retrospective database study
inferred← citeshttps://doi.org/10.1007/s11239-013-0897-9openalex-snapshot
Pathophysiology and management of thrombosis in cancer: 150 years of progress
inferred← citeshttps://doi.org/10.1007/s11239-013-1014-9openalex-snapshot
Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis
inferred← citeshttps://doi.org/10.1007/s11239-015-1187-5openalex-snapshot
Inferior vena cava filters: current best practices
inferred← citeshttps://doi.org/10.1007/s11239-017-1478-0openalex-snapshot
Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study
inferred← citeshttps://doi.org/10.1007/s11239-018-1774-3openalex-snapshot
Venous thromboembolism in patients with cancer undergoing surgical exploration
inferred← citeshttps://doi.org/10.1007/s11239-019-01834-9openalex-snapshot
Practice patterns of VTE chemoprophylaxis after discharge following hepatic and pancreatic resections for cancer: A survey of hepatopancreatobiliary surgeons
inferred← citeshttps://doi.org/10.1007/s11605-012-1939-xopenalex-snapshot
Venous Thromboembolism After Hepatic Resection: Analysis of 5,706 Patients
inferred← citeshttps://doi.org/10.1007/s11605-014-2647-5openalex-snapshot
A Nationwide Analysis of Postoperative Deep Vein Thrombosis and Pulmonary Embolism in Colon and Rectal Surgery
inferred← citeshttps://doi.org/10.1007/s11605-018-04075-yopenalex-snapshot
Do All Abdominal Neuroendocrine Tumors Require Extended Postoperative VTE Prophylaxis? A NSQIP Analysis
inferred← citeshttps://doi.org/10.1007/s11605-018-04085-wopenalex-snapshot
Postoperative Portomesenteric Venous Thrombosis After Colorectal Cancer Surgery
inferred← citeshttps://doi.org/10.1007/s11606-016-3603-8openalex-snapshot
Effects of Long-Term Low-Molecular-Weight Heparin on Fractures and Bone Density in Non-Pregnant Adults: A Systematic Review With Meta-Analysis
inferred← citeshttps://doi.org/10.1007/s11739-008-0196-1openalex-snapshot
Risk and prophylaxis of catheter-related venous thromboembolism after cardiac surgery: where is the evidence?
inferred← citeshttps://doi.org/10.1007/s11739-010-0359-8openalex-snapshot
Venous thromboembolism prophylaxis with unfractionated heparin in the hospitalized medical patient: the case for thrice daily over twice daily dosing
inferred← citeshttps://doi.org/10.1007/s11845-008-0200-9openalex-snapshot
Management of refractory venous thrombosis associated with malignancy using a supra-therapeutic enoxaparin regimen
inferred← citeshttps://doi.org/10.1007/s11864-008-0077-xopenalex-snapshot
Treatment of Hematologic Neoplasms with New Immunomodulatory Drugs (IMiDs)
inferred← citeshttps://doi.org/10.1007/s11864-012-0207-3openalex-snapshot
The Therapeutic Management of Bleeding and Thrombotic Disorders Complicating CNS Malignancies
inferred← citeshttps://doi.org/10.1007/s11936-011-0112-2openalex-snapshot
Approach to Venous Thromboembolism in the Cancer Patient
inferred← citeshttps://doi.org/10.1007/s11936-018-0618-yopenalex-snapshot
Cardiovascular Complications of Multiple Myeloma Treatment: Evaluation, Management, and Prevention
inferred← citeshttps://doi.org/10.1007/s11936-019-0764-xopenalex-snapshot
Prevention and Treatment of Cancer-Associated Venous Thromboembolism: a Review
inferred← citeshttps://doi.org/10.1007/s11940-011-0132-yopenalex-snapshot
Medical Management of Patients With Brain Tumors
inferred← citeshttps://doi.org/10.1007/s11999-008-0607-7openalex-snapshot
IVC Filters May Prevent Fatal Pulmonary Embolism in Musculoskeletal Tumor Surgery
inferred← citeshttps://doi.org/10.1007/s12032-009-9289-6openalex-snapshot
Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab
inferred← citeshttps://doi.org/10.1007/s12094-008-0268-8openalex-snapshot
Idiopathic and recurrent thromboembolic phenomena in cancer patients
inferred← citeshttps://doi.org/10.1007/s12094-014-1165-yopenalex-snapshot
Incidence of venous thromboembolism (VTE) in ambulatory pancreatic cancer patients receiving chemotherapy and analysis of Khorana’s predictive model
inferred← citeshttps://doi.org/10.1007/s12094-020-02336-4openalex-snapshot
The effectiveness and safety of thromboprophylaxis in cancer patients based on Khorana score: a meta-analysis and systematic review of randomized controlled trials
inferred← citeshttps://doi.org/10.1007/s12094-020-02506-4openalex-snapshot
Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence
inferred← citeshttps://doi.org/10.1007/s12156-010-0042-3openalex-snapshot
Inferior vena cava filters in the management of cancer-associated venous thromboembolism: a systematic review
inferred← citeshttps://doi.org/10.1007/s12156-011-0079-yopenalex-snapshot
Prevention of venous thromboembolism in cancer patients: current approaches and opportunities for improvement
inferred← citeshttps://doi.org/10.1007/s12185-020-02928-4openalex-snapshot
New insights on patient-related risk factors for venous thromboembolism in patients with solid organ cancers
inferred← citeshttps://doi.org/10.1007/s12185-024-03736-wopenalex-snapshot
Clinical guidelines for prevention and treatment of CAT in Japan and other countries
inferred← citeshttps://doi.org/10.1007/s12253-015-0008-7openalex-snapshot
Predictors of Venous Thromboembolism in Patients with Glioblastoma
inferred← citeshttps://doi.org/10.1007/s12288-014-0496-8openalex-snapshot
Pattern of Venous Thrombosis in Cancer Patients: Frequency and Survival Effect; Single Center Experience
inferred← citeshttps://doi.org/10.1007/s12325-015-0187-3openalex-snapshot
The Cost of Thromboembolic Events in Hospitalized Patients with Breast or Prostate Cancer in France
inferred← citeshttps://doi.org/10.1007/s13258-023-01404-7openalex-snapshot
Transcriptomic analysis of neutrophil apoptosis induced by diffuse large B-cell lymphoma unveils a potential role in neutropenia
inferred← citeshttps://doi.org/10.1007/s13277-015-3117-8openalex-snapshot
Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism
inferred← citeshttps://doi.org/10.1007/s15015-012-0426-2openalex-snapshot
Gerinnungsstörungen und Thrombosen bei onkologischen Patienten
inferred← citeshttps://doi.org/10.1007/s40261-015-0299-1openalex-snapshot
Evaluation of Pharmacokinetic and Pharmacodynamic Interactions when Lenalidomide is Co-administered with Warfarin in a Randomized Clinical Trial Setting
inferred← citeshttps://doi.org/10.1007/s40262-012-0009-6openalex-snapshot
Inter-Individual Differences in Baseline Coagulation Activities and Their Implications for International Normalized Ratio Control During Warfarin Initiation Therapy
inferred← citeshttps://doi.org/10.1016/b978-0-12-387837-3.00024-9openalex-snapshot
The Role of Platelets in Angiogenesis
inferred← citeshttps://doi.org/10.1016/b978-0-12-802997-8.00015-3openalex-snapshot
Vascular complications in glioma patients
inferred← citeshttps://doi.org/10.1016/b978-0-323-05905-3.00020-0openalex-snapshot
Complications of Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-323-46202-0.00023-6openalex-snapshot
Thrombosis and Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-323-61204-3.00068-3openalex-snapshot
Superior Vena Cava Occlusive Disease
inferred← citeshttps://doi.org/10.1016/b978-0-323-69584-8.00037-2openalex-snapshot
Special Considerations in the Postoperative Care of the Cancer Patient
inferred← citeshttps://doi.org/10.1016/b978-1-4160-5223-4.00037-8openalex-snapshot
Hypercoagulable States
inferred← citeshttps://doi.org/10.1016/b978-1-4377-0398-6.00077-9openalex-snapshot
Pulmonary Embolism
inferred← citeshttps://doi.org/10.1016/b978-1-4377-1015-1.00009-6openalex-snapshot
Management of cardiac and pulmonary treatment–related side effects
inferred← citeshttps://doi.org/10.1016/b978-1-4377-1015-1.00026-6openalex-snapshot
Thrombosis in cancer
inferred← citeshttps://doi.org/10.1016/b978-1-4377-1724-2.00004-0openalex-snapshot
Postoperative Management
inferred← citeshttps://doi.org/10.1016/b978-1-4557-0984-7.00273-8openalex-snapshot
10.1016/b978-1-4557-0984-7.00273-8
inferred← citeshttps://doi.org/10.1016/b978-1-4557-2296-9.00031-2openalex-snapshot
Use of Vena Cava Filters and Venous Access Devices
inferred← citeshttps://doi.org/10.1016/b978-1-4557-2865-7.00035-7openalex-snapshot
Diagnosis, Treatment, and Prevention of Cancer-Associated Venous Thromboembolism
inferred← citeshttps://doi.org/10.1016/b978-2-294-71346-0.50001-xopenalex-snapshot
Pathologie Veineuse Aiguë
inferred← citeshttps://doi.org/10.1016/b978-2-294-71346-0.50025-2openalex-snapshot
Cancer et Vaisseaux
inferred← citeshttps://doi.org/10.1016/b978-3-437-24706-4.00002-3openalex-snapshot
Perioperative Medizin und Intensivmedizin
inferred← citeshttps://doi.org/10.1016/b978-84-8086-956-0.00077-0openalex-snapshot
10.1016/b978-84-8086-956-0.00077-0
inferred← citeshttps://doi.org/10.1016/j.aju.2015.11.002openalex-snapshot
Venous thromboembolism after radical cystectomy: Experience with screening ultrasonography
showing the first 200 of 910 · page through all 910
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.